eFFECTOR Therapeutics, Inc.

OTCPK:EFTR Stock Report

Market Cap: US$1.4k

eFFECTOR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:EFTR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Nov 23SellUS$369,457SR One Capital Management, LPCompany24,366.52US$15.16
21 Nov 23SellUS$2,465,238The Column Group, LLCCompany163,669.36US$15.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EFTR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders47,1621%
Public Companies75,1521.6%
Hedge Funds352,0847.48%
Institutions643,60413.7%
General Public3,586,40776.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 90.4%.

Top Shareholders

Top 25 shareholders own 23.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.48%
Sabby Management, LLC
352,084US$105.60%no data
4.1%
Abingworth LLP
192,884US$57.90%no data
2.4%
Altitude Life Science Ventures
113,054US$33.90%100.0%
1.6%
Pfizer Inc.
75,152US$22.50%no data
1.44%
Parallel Advisors, LLC
67,738US$20.30%no data
1.31%
UBS Asset Management AG
61,667US$18.50%no data
1.11%
Blackstone Inc.
52,343US$15.70%no data
0.74%
Stephen Worland
34,987US$10.55.44%no data
0.54%
Geode Capital Management, LLC
25,583US$7.713.2%no data
0.53%
The Vanguard Group, Inc.
25,070US$7.5-72.9%no data
0.46%
Hudson River Trading LLC, Asset Management Arm
21,528US$6.50%no data
0.4%
Jane Street Group, LLC, Asset Management Arm
18,669US$5.60%no data
0.38%
Virtu Financial LLC, Asset Management Arm
18,021US$5.40%no data
0.31%
Pfizer Venture Investments LLC
14,602US$4.40%no data
0.24%
Two Sigma Investments, LP
11,115US$3.30%no data
0.22%
Sea Otter Advisors LLC
10,557US$3.20%no data
0.21%
Tower Research Capital Europe Limited
9,805US$2.9539%no data
0.15%
Christopher Ehrlich
7,136US$2.10%no data
0.066%
Michael Byrnes
3,117US$0.980.2%no data
0.026%
Brian Gallagher
1,200US$0.40%no data
0.012%
Royal Bank of Canada, Banking & Securities Investments
546US$0.226.4%no data
0.0077%
Caroline Loewy
361US$0.10%no data
0.0077%
Elizabeth Bhatt
361US$0.10%no data
0.0051%
Morgan Stanley, Investment Banking and Brokerage Investments
240US$0.07-85.1%no data
0.0021%
Barclays Bank PLC, Securities Investments
100US$0.030%no data